New data from North American and Chinese clinical trials reinforce the safety, efficacy, and durability of DOT lenses in slowing pediatric myopia progression, without evidence of rebound.
Debbie Laughton, BSc, PhD
Advertisement
Articles by Debbie Laughton, BSc, PhD
Advertisement
Latest Updated Articles
Clinical trial Q&A: New data on DOT lenses show strong global performance in myopia controlPublished: May 27th 2025 | Updated:
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
AAOpt 2025: Where low-level light therapies stand as dry eye treatments and myopia management
2
AAOpt 2025: New approaches to managing age-related eye conditions
3
AAOpt 2025: Dry eye and its neurological implications
4
Epion Therapeutics granted FDA Fast Track designation for EpiSmart corneal cross-linking
5
.png "Optometry Times"){kind=logo}
